World's Best Scientists 2026 revealed!
Award Badge
Immunology
USA
2026

D-Index & Metrics

Immunology

D-Index
158
Citations
96199
World Ranking
88
National Ranking
57

Medicine

D-Index
158
Citations
96199
World Ranking
848
National Ranking
483

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Immunology in United States Leader Award
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Steven G. Deeks is affiliated with the University of California, San Francisco in the United States. Their research focuses primarily on the fields of Medicine and Immunology and Microbiology, with extensive work in infectious diseases, virology, immunology, neurology, and molecular biology.

The scientist's main research interests include HIV Research and Treatment, HIV/AIDS Research and Interventions, Immune Cell Function and Interaction, Long-Term Effects of COVID-19, HIV/AIDS drug development and treatment, COVID-19 Clinical Research Studies, and SARS-CoV-2 and COVID-19 Research.

Frequent coauthors of Steven G. Deeks comprise Rebecca Hoh, Michael J. Peluso, Timothy J. Henrich, Jeffrey N. Martin, and J. Daniel Kelly.

Key publication venues where the scientist has contributed significantly include bioRxiv (Cold Spring Harbor Laboratory), UNC Libraries, The Journal of Infectious Diseases, JCI Insight, and Journal of Virus Eradication.

Significant recent papers authored or coauthored by Steven G. Deeks include:

  • Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021 (2021, Nature Medicine)
  • Distinct viral reservoirs in individuals with spontaneous control of HIV-1 (2020, Nature)
  • Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection (2021, The Journal of Infectious Diseases)
  • Serotonin reduction in post-acute sequelae of viral infection (2023, Cell)
  • The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies (2020, Cell Host & Microbe)

Steven G. Deeks has been recognized as a member of the Association of American Physicians.

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Microbial translocation is a cause of systemic immune activation in chronic HIV infection

    Jason M. Brenchley;David A. Price;Timothy W. Schacker;Tedi E. Asher

  • The end of AIDS: HIV infection as a chronic disease

    Steven G Deeks;Sharon Ruth Lewin;Sharon Ruth Lewin;Diane V Havlir

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Effect of early versus deferred antiretroviral therapy for HIV on survival.

    Mari M. Kitahata;Stephen J. Gange;Alison G. Abraham;Barry Merriman

  • HIV Infection, Inflammation, Immunosenescence, and Aging

    Steven G. Deeks

  • Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection

    Netanya Sandler;Handan Wand;Annelys Roque;Matthew G Law

  • HIV-1 protease inhibitors. A review for clinicians.

    Steven G. Deeks;Mark Smith;Mark Holodniy;James O. Kahn

  • Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

    Steven G. Deeks;Christina M. R. Kitchen;Lea Liu;Hua Guo

  • Systemic Effects of Inflammation on Health during Chronic HIV Infection

    Steven G. Deeks;Russell Tracy;Daniel C. Douek

  • Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy

    Steven G. Deeks;Steven G. Deeks;Bruce D. Walker;Bruce D. Walker

  • Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1

    Maureen P. Martin;Ying Qi;Xiaojiang Gao;Eriko Yamada

  • Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

    Steven G. Deeks;Terri Wrin;Teri Liegler;Rebecca Hoh

  • HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.

    Steven G Deeks;Andrew N Phillips

  • HIV: Shock and kill

    Steven G Deeks

  • T Cell Activation Is Associated with Lower CD4+ T Cell Gains in Human Immunodeficiency Virus-Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy

    Peter W Hunt;Jeffrey N Martin;Elizabeth Sinclair;Barry Bredt

  • Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism

    Ivan Vujkovic-Cvijin;Richard M. Dunham;Shoko Iwai;Michael C. Maher

  • Relationship between T Cell Activation and CD4+ T Cell Count in HIV-Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy

    Peter W. Hunt;Jason Brenchley;Elizabeth Sinclair;Joseph M. McCune

  • Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans

    M Hellerstein;M B Hanley;D Cesar;S Siler

  • Defective proviruses rapidly accumulate during acute HIV-1 infection.

    Katherine M. Bruner;Alexandra J. Murray;Ross A. Pollack;Mary G. Soliman

  • Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells

    John Scholler;Troy L. Brady;Gwendolyn Binder-Scholl;Wei-Ting Hwang

  • Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral-Treated HIV Infection

    Wei Jiang;Michael M. Lederman;Peter Hunt;Scott F. Sieg

Frequent Co-Authors

Jeffrey N. Martin
Jeffrey N. Martin University of California, San Francisco
Peter W. Hunt
Peter W. Hunt University of California, San Francisco
Frederick Hecht
Frederick Hecht University of California, San Francisco
Joseph M. McCune
Joseph M. McCune University of California, San Francisco
Rebecca Hoh
Rebecca Hoh University of California, San Francisco
Elizabeth Sinclair
Elizabeth Sinclair University of California, San Francisco
Sharon R. Lewin
Sharon R. Lewin University of Melbourne
Michael P. Busch
Michael P. Busch University of California, San Francisco
Bruce D. Walker
Bruce D. Walker Harvard University
Douglas F. Nixon
Douglas F. Nixon Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and scientific careers. For those interested in advancing clinical expertise, exploring online BSN programs for non nurses can provide a smooth transition into nursing without prior experience. These programs often offer flexible learning formats tailored to busy professionals.

If you seek a faster route into nursing, several ABSN programs with high acceptance rates are worth considering. These accelerated options are designed for individuals holding a bachelor’s degree in another field, making it easier to switch careers.

For those starting at the entry level, identifying which LPN programs are easiest to get into can be crucial. Licensed Practical Nurse programs often serve as a practical first step towards building clinical skills and further advancing in healthcare.

Lastly, many Immunology graduates looking to specialize can explore the easiest NP program options. Nurse Practitioner degrees offer opportunities to work independently, often with a focus on patient care and leadership in healthcare settings.

Best Scientists Citing Steven G. Deeks

Trending Scientists

Recently Published Articles